Evidence map›Paper›PMID 42384115›Full record

ArticleJournal of community genetics2026

Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025.

Angus Clarke, Ruth Horn, Elena Avram, Siddarth Banka, Felicity Boardman, Victoria Charlton, Mike Drummond, Roseline Favresse, Angeline Ferdinand, David Freis and 18 more

Abstract read
In one paragraph

Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Angus ClarkeCardiff University, Wales, UK. clarkeaj@cardiff.ac.uk.
Ruth HornUniversity of Augsburg, Augsburg, Germany.
Elena AvramMedlife Clinics, Bucharest, Romania.
Siddarth BankaDivision of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Centre for Genomic Medicine, Health Innovation Manchester, University of Manchester and, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Felicity BoardmanUniversity of Warwick, Coventry, England, UK.
Victoria CharltonLondon School of Economics, London, England, UK.
Mike DrummondUniversity of York, York, England, UK.
Roseline FavresseEURORDIS, Paris, France.
Angeline FerdinandUniversity of Melbourne, Victoria, Australia.
David FreisUniversity of Augsburg, Augsburg, Germany.
Ilaria GalassoUniversity College Dublin, Dublin , Ireland.
Nadine Z GroßmannFOP e.V., International FOP Association (IFOPA), Freie Universität, Berlin, Germany.
Meghan HalleyCenter for Biomedical Ethics, Stanford University, Stanford, CA, USA.
Sasha HenriquesGenomics England, London, UK.
Hadewych HonnéUniversity of Edinburgh, Edinburgh, Scotland, UK.
Sofia Douzgou HougeHaukeland University Hospital, Bergen, Norway.
Salman KirmaniMedical Genetics and Paediatric Endocrinology, Medical College, The Aga Khan University, Karachi, Pakistan.
Tamar Nov KlaimanUniversity of Augsburg, Augsburg, Germany.
Teodora Lalova-SpinksDepartment of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Charlotta Ingvoldstad MalmgrenCenter for Rare Diseases, Department for clinical genetics, Karolinska University Hospital, Stockholm, Sweden.
Nick MeadeGenetic Alliance UK, London, England, UK.
Elena NicodDolon Ltd., London, UK.
Kelly E OrmondETH-Zürich, Zürich, Switzerland.
Barbara PrainsackUniversity of Vienna, Vienna, Austria.
Hilde Van Esch, Leuven, Belgium.
Ambroise WonkamJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sarah L WynnUNIQUE, London, England, UK.
Francesca ForzanoGuys and St Thomas' NHS Foundation Trust and Faculty of Life Sciences, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomics is transforming health care but its implementation raises challenges. This paper reports a 2025 workshop on justice in the implementation of genomics for rare disorders. The workshop goals were to develop a consensus understanding of the problems faced by rare disease patients and families where justice is at stake, to achieve a shared perspective on support for rare disease patients, and to consider the implications for justice in several areas of rare disease genomics, in both research and healthcare. We heard about the diverse experiences and needs of patients. Inequity between different rare diseases is marked. The need for coordination of care for rare disease patients is under-recognized but good models of rare disease care exist. The value of conscientious professionalism to nurture a rare disease mindset needs to be emphasized in the training of each new generation of healthcare students//trainees. The circumstances of different population groups differ systematically. The needs of indigenous and other historically marginalised groups must also be addressed. However, the subordination of individuals to the benefit of the population (i.e. eugenics) must be resisted. Those engaged in genomics projects or diagnostics may need protection from hype and misuse of their personal data, There are different perspectives on the fair allocation of resources to healthcare and research for rare conditions. Health economics and health technology assessment can be practised equitably, so as to meet the challenges of rare disease clinical trials and address the needs of patients and communities.

Identifiers

PMID42384115
PMCPMC13323455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.